1. bookVolume 74 (2020): Issue 6 (December 2020)
Journal Details
License
Format
Journal
eISSN
2255-890X
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
access type Open Access

Second European Cardiac Resynchronisation Therapy Survey (Crt Survey Ii): Latvian Data Compared to Europe

Journal Details
License
Format
Journal
eISSN
2255-890X
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
Abstract

The cardiac resynchronisation therapy (CRT) survey II is a joint initiative between the European Heart Rhythm Association and the Heart Failure Association. It compiles real world data about cardiac resynchronisation therapy in European Society of Cardiology member states. 11 088 patients assigned to implantation of CRT with pacemaker function (CRT-P) or CRT with an incorporated defibrillator (CRT-D) were enrolled in the survey starting 1 October 2015 till 31 December 2016 and for each patient, an electronic case report form (eCRF) was completed. Each participating country had each eCRF data-point benchmarked against the total cohort. In total, 79 patients were included from Latvia. The mean age of patients was 68.1, similar to the total cohort of other ESC member states, and 21.8% of patients were female. Latvian patients compared to other countries more often had permanent atrial fibrillation, NYHA class III and IV, ejection fraction 35 %. CRT-Ds and multipolar lead implantation rates were higher. Peri-procedural complication rates were similarly low in both groups. At discharge, prescribed medication rates were similar but more frequently MRAs, ivabradine and calcium channel blockers were prescribed and slightly less frequently ACE inhibitors/ARBs were prescribed. The CRT survey II is a valuable resource that describes ongoing practice of cardiac resynchronisation therapy around Europe and benchmarking against the total cohort is nationally significant for each participating country.

Keywords

Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L et al. (2002). Cardiac resynchronization in chronic heart failure. New Engl. J. Med., 346 (24), 1845–1853.10.1056/NEJMoa01316812063368Search in Google Scholar

Barra, S., Providźncia, R., Agarwal, S., Marijon, E., Boveda, S. (2017). The benefit of cardiac resynchronization therapy is not hindered by the number of comorbidities. J. Amer. Coll. Cardiol., 70 (16), 2096–2097.10.1016/j.jacc.2017.06.07729025565Search in Google Scholar

Brignole, M., Auricchio, A., Baron-Esquivias, G., Bordachar, P., Boriani, G, Breithardt, O. A., Cleland, J., Deharo, J. C, Delgado, V., Elliott, P. M. et al. (2013). 2013 ESC Guidelines on cardiac pacing and cardiacre-synchronization therapy. Eur. Heart J.,34, 2281–2329.Search in Google Scholar

Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., Garrigue, S., Kappenberger, L., Haywood, G. A., Santini, M., Bailleul, C., Daubert, J. C., Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New Engl. J. Med.,344 (12), 873–880.10.1056/NEJM20010322344120211259720Search in Google Scholar

Chung, E. S., Katra, R. P., Ghio, S., Bax, J., Gerritse, B., Hilpisch, K., Peterson, B. J., Feldman, D. S., Abraham, W. T. (2010). Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction 35%: a PROSPECT trial substudy. Eur. J. Heart Failure,12 (6), 581–587.10.1093/eurjhf/hfq00920150328Search in Google Scholar

Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Tavazzi, L. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New Engl. J. Med., 352, 1539–1549.10.1056/NEJMoa05049615753115Search in Google Scholar

Cullington, D., Goode, K. M., Clark, A. L., Cleland, J. G. (2012), Heart rate achieved or beta-blocker dose in patients with chronic heart failure: Which is the better target? Eur. J. Heart Failure, 14, 737–747.10.1093/eurjhf/hfs06022622001Search in Google Scholar

Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J., Scientific Committee, National Coordinators (2009). The European cardiac resynchronization therapy survey. Eur. Heart J.,30 (20), 2450–2460.10.1093/eurheartj/ehp35919723694Search in Google Scholar

Dickstein, K., Normand, C., Anker, S. D., Auricchio, A., Blomström-Lundqvist, C., Bogale, N., Cleland, J., Filippatos, G., Gasparini, M., Gitt, A., Hindricks, G., Kuck, K.H., Ponikowski, P., Stellbrink, C., Ruschitzka, F., Linde, C. (2015). European Cardiac Resynchronization Therapy Survey II: rationale and design. EP Europace, 17 (1), 137–141.10.1093/europace/euu31225414481Search in Google Scholar

Dickstein, K., Normand, C., Auricchio, A., Bogale, N., Cleland, J. G., Gitt, A. K., Stellbrink, C., Anker, S. D., Filippatos, G., Gasparini, M. et al. (2018). CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients — who is doing what to whom and how? Eur. J. Heart Failure, 20, 1039–1051.10.1002/ejhf.114229457358Search in Google Scholar

Farwell, D., Patel, N. R., Hall, A., Ralph, S., Sulke, A. N. (2000). How many people with heart failure are appropriate for biventricular resynchronization? Eur. Heart J.,21 (15), 1246–1250.10.1053/euhj.1999.198510924314Search in Google Scholar

Gurevitz, O., Nof, E., Carasso, S., Luria, D., Bar-Lev, D., Tanami, N., Eldar, M., Glikson, M. (2005). Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin. Electrophysiol., PACE, 28 (12), 1255–1259.10.1111/j.1540-8159.2005.00265.xSearch in Google Scholar

Hayes, D. L., Boehmer, J. P., Day, J. D., Gilliam, F. R., 3rd, Heidenreich, P. A., Seth, M., Jones, P. W., Saxon, L. A. (2011). Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm, 8 (9), 1469–1475.10.1016/j.hrthm.2011.04.015Search in Google Scholar

Linde, C., Curtis, A. B., Fonarow, G. C., Lee, K., Little, W., Tang, A., Levya, F., Momomura, S., Manrodt, C., Bergemann, T., Cowie, M. R. (2016). Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study. Int. J. Cardiol.,202, 349–355.10.1016/j.ijcard.2015.09.023Search in Google Scholar

Maggioni, A.P., Anker, S.D., Dahlström, U., Filippatos, G., Ponikowski, P., Zannad, F., Amir, O., Chioncel, O., Leiro, M.C., Drozdz, J., Erglis, A. et al. (2013). Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry. Eur. J. Heart Failure, 15, 1173–1184.10.1093/eurjhf/hft134Search in Google Scholar

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. 3rd, Foster, E., Greenberg, H., Higgins, S. L., Pfeffer, M. A., Solomon, S. D., Wilber, D., Zareba, W. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New Engl. J. Med.,361, 1329–1338.10.1056/NEJMoa0906431Search in Google Scholar

Ni, H., Xu, J. (2015). Recent trends in heart failure-related mortality: United States, 2000–2014. NCHS data brief, (231), 1–8.Search in Google Scholar

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. H., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A. et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. J. Heart Failure, 18 (8), 891–975.10.1002/ejhf.592Search in Google Scholar

Savarese, G., Lund, L. H. (2017). Global public health burden of heart failure. Cardiac Failure Rev., 3 (1), 7–11.10.15420/cfr.2016:25:2Search in Google Scholar

Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., Tavazzi, L., SHIFT Investigators (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet,376 (9744), 875–885.10.1016/S0140-6736(10)61198-1Search in Google Scholar

Swedberg, K., Komajda, M., Böhm, M., Borer, J., Robertson, M., Tavazzi, L., Ford, I., SHIFT Investigators (2012). Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose? J. Amer. Coll. Cardiol.,59 (22), 1938–1945.10.1016/j.jacc.2012.01.020Search in Google Scholar

Witt, C. M., Wu, G., Yang, D., Hodge, D. O., Roger, V. L., Cha, Y. M. (2016). Outcomes with left bundle branch block and mildly to moderately reduced left ventricular function. JACC. Heart Failure, 4 (11), 897–903.10.1016/j.jchf.2016.07.00227614941Search in Google Scholar

Zeitler, E. P., Friedman, D. J., Daubert, J. P., Al-Khatib, S. M., Solomon, S. D., Biton, Y., McNitt, S., Zareba, W., Moss, A. J., Kutyifa, V. (2017). Multiple comorbidities and response to cardiac resynchronization therapy: MADIT-CRT long-term follow-up. J. Amer. Coll.Cardiol.,69 (19), 2369–2379.10.1016/j.jacc.2017.03.531649947928494974Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo